Microplastics Entering Living Systems: Discovery Pathways, Experimental Evidence, and Global Responses

Abstract

Microplastics and nanoplastics have evolved from a marine-pollution issue into a systemic risk topic spanning ecology, toxicology, food safety, occupational exposure, public health, and global governance. In 1972, researchers reported plastic particles on the surface of the Sargasso Sea. In 2004, Thompson and colleagues brought the concept of “microplastics” into mainstream scientific language through their Science article. Over the following two decades, evidence showed that microplastics can occur in seawater, sediments, drinking water, air, food webs, and many living organisms, with experimental signals including altered feeding, tissue translocation, inflammation, oxidative stress, reproductive disruption, and metabolic disturbance.

Human studies have reported plastic particles in stool, placenta, blood, lung tissue, breast milk, and atherosclerotic plaques. The 2024 New England Journal of Medicine study on microplastics and nanoplastics in carotid plaques sharply increased medical attention to possible cardiovascular relevance. However, current human evidence remains dominated by detection studies, cross-sectional work, and observational associations. Detection is not the same as completed proof that microplastics cause a specific disease. The central risk profile is therefore not a reason for panic, but a reason for precaution: exposure is widespread, persistence is high, reversibility is uncertain, mechanisms are biologically plausible, and the human causal chain is still incomplete. Personal habit change, product redesign, food-contact material governance, textile-fiber control, waste management, standardized monitoring, and international treaty coordination should advance together.

Evidence layer	Representative finding	Reasonable conclusion	Overstatement to avoid
Environmental detection	Detection in sea surface water, sediments, drinking water, and air	Microplastics are global contaminants	Detection alone does not quantify human disease risk
Ecological experiments	Mussel translocation, oyster reproductive disruption, fish hepatic stress	Microplastics can produce measurable biological effects	Laboratory dose, size, and polymer type must be separated from real exposure
Human detection	Stool, placenta, blood, lung, breast milk, arterial plaques	Multiple routes of exposure and internal exposure are plausible	Detection does not prove all proposed health outcomes
Medical association	MNPs in arterial plaques associated with cardiovascular events	Long-term chronic-disease research is justified	Observational association does not replace causal proof
Policy response	Microbead bans, EU REACH restriction, UN plastics treaty negotiations	Governance is moving from cleanup toward source control	Recycling or personal choice alone cannot solve systemic release

1. Introduction: From Ocean Fragments to Living Systems

The modern value of plastic comes from stability, light weight, low cost, and scalable manufacturing. The modern risk of plastic pollution comes from the same properties. Large plastic debris does not simply disappear. It fragments through ultraviolet radiation, mechanical abrasion, weathering, washing, tire wear, packaging degradation, and industrial pellet loss into smaller fragments, fibers, and particles. In common usage, plastic particles smaller than 5 mm are called microplastics; nanoplastics are becoming a major focus because they may cross biological barriers more readily.

Early plastic-pollution research emphasized visible harm such as seabirds, turtles, or fish ingesting large debris or becoming entangled in fishing gear. With the development of microscopy, infrared spectroscopy, Raman spectroscopy, and pyrolysis-gas chromatography/mass spectrometry, scientists realized that the harder problem was not only floating litter but also microscopic particles dispersed into water, soil, air, and biological tissues. Plastic pollution thereby shifted from an environmental-cleanliness issue to an ecological and human-exposure issue.

2. Discovery Pathway: From the Sargasso Sea to the Concept of Microplastics

In 1972, Carpenter and Smith reported plastic particles on the surface of the Sargasso Sea in Science, with average concentrations in the thousands of pieces per square kilometer. The finding was historically important because it showed that plastic fragments could be transported and accumulated even in oceanic regions far from land. In the same year, Carpenter and colleagues also reported polystyrene spherules in coastal waters, indicating that both industrial pellets and post-consumer fragments could become sources of small plastic pollution.

In 2004, Thompson and colleagues published Lost at sea: where is all the plastic? in Science, reporting widespread microscopic plastic fragments and fibers in marine water and sediments and helping establish “microplastics” as a global scientific term. Research then moved rapidly from “how much plastic is floating at sea” to “how plastic enters food webs, crosses tissue barriers, transports chemicals, and may affect human health.”

3. Exposure Pathways: How Microplastics Enter Organisms

Microplastics enter living organisms mainly through three routes. The first is ingestion, including drinking water, seafood, salt, packaged food, bottled water, takeout containers, and foods contaminated by environmental particles. The second is inhalation from indoor dust, synthetic textiles, tire-wear particles, urban air, and occupational environments. The third includes special medical or lifestyle scenarios, such as contact with medical devices, infusion systems, disposable plastics, and plastic-packaged foods or fluids.

Microplastics are not a single substance. They are mixtures that differ by polymer, size, shape, additives, aging state, and surface biofilm. Polyethylene, polypropylene, polystyrene, polyethylene terephthalate, polyvinyl chloride, and nylon have different properties. Fragments, fibers, films, pellets, and foams may behave differently in biology. Risk assessment must therefore ask not only whether plastic is present, but what polymer, what size, what shape, what additive load, what dose, and what exposure duration.

4. Ecological and Experimental Evidence: The Risk Is Not Hypothetical

Ecotoxicological studies provide important evidence that microplastics can affect organisms. Browne and colleagues showed that ingested microscopic plastic could translocate from the gut to the circulatory system of the mussel Mytilus edulis and persist in tissues. This shifted the understanding of microplastics from inert particles that simply pass through the gut toward particles that may cross biological boundaries under certain conditions.

In oysters, Sussarellu and colleagues found that polystyrene microplastic exposure affected feeding and reproduction, with consequences for offspring. Rochman and colleagues reported that ingested plastic could transfer hazardous chemicals to fish and induce hepatic stress. These studies do not mean the same effects occur at all environmental concentrations, but they establish a critical point: microplastics have biological activity potential and should not be dismissed as harmless inert dust.

5. Human Evidence: From Detection to Medical Concern

Human evidence has expanded quickly. In 2019, Schwabl and colleagues detected several plastic types in stool samples from healthy volunteers, showing that oral exposure can be observed in biological samples. In 2021, Ragusa and colleagues reported microplastics in human placental samples, making pregnancy exposure, placental barriers, and developmental risk a new area of concern. In 2022, Leslie and colleagues quantified plastic particle pollution in human blood, suggesting that plastic particles or smaller fractions may reach circulation. The same year, Jenner and colleagues detected microplastics in human lung tissue, supporting further research on inhalation and lung deposition.

In 2024, Marfella and colleagues reported microplastics and nanoplastics in carotid plaques in the New England Journal of Medicine and observed a higher risk of a composite of myocardial infarction, stroke, or death among patients with detectable particles. This study attracted major medical attention because it linked MNPs in human tissue with serious clinical outcomes. At the same time, it remains observational and cannot prove causality by itself. A careful conclusion is that plastic particles have moved from an environmental-exposure marker into the research space of possible chronic-disease risk factors, requiring larger, standardized, long-term cohort studies.

6. Potential Mechanisms: Particles, Chemicals, and Biofilms

Microplastic hazards are usually discussed through three mechanisms. The first is particle-related physical interaction, including irritation of cell membranes, mucosal barriers, alveolar regions, or intestinal epithelium, and immune-cell uptake followed by inflammatory signaling. The second is chemical action from additives, plasticizers, flame retardants, stabilizers, residual monomers, and environmental contaminants such as persistent organic pollutants or metals adsorbed onto particle surfaces. The third is microbial action: plastic surfaces can form biofilms that carry microorganisms and resistance genes.

Cell and animal studies repeatedly report oxidative stress, inflammatory signaling, gut-barrier impairment, metabolic disturbance, reproductive toxicity, and immune modulation. For humans, the scientific challenge is that real exposure is usually low-dose, long-term, multi-source, multi-polymer, and mixed-size exposure, entangled with diet, air pollution, occupation, socioeconomic variables, and baseline disease. Microplastic health research should therefore build an evidence chain connecting exposomics, toxicology, epidemiology, and clinical cohorts rather than searching for a single answer.

7. Global Governance: From Microbead Bans to Full-Life-Cycle Plastic Policy

Early national policy often began with microbeads. The United States passed the Microbead-Free Waters Act in 2015, prohibiting rinse-off cosmetics containing plastic microbeads. Canada published the Microbeads in Toiletries Regulations in 2017, restricting manufacture, import, and sale of toiletries containing plastic microbeads. The United Kingdom implemented a ban on microbeads in rinse-off cosmetics and personal care products in 2018. China’s 2020 policy on strengthening plastic pollution control banned production of daily chemical products containing plastic microbeads by the end of 2020 and banned sales by the end of 2022. The European Union adopted Regulation (EU) 2023/2055 under REACH, creating a broader restriction on synthetic polymer microparticles intentionally added to products.

At the international level, the United Nations Environment Assembly adopted Resolution 5/14 in 2022 to develop an international legally binding instrument on plastic pollution, including in the marine environment. The Intergovernmental Negotiating Committee has continued negotiations since then. As of 2 July 2026, the global plastics treaty process remains under negotiation and follow-up coordination, without a final enforceable treaty text. Key disputes include whether to limit virgin plastic production, whether to cover the full plastic life cycle, how to regulate additives, how to support developing countries, and whether to establish binding monitoring and compliance mechanisms.

Governance level	Representative measure	Value	Limitation
Individual	Less bottled water, fewer disposable utensils, lower microfiber release	Reduces some controllable exposure and sends market signals	Cannot redirect production and waste flows alone
Product	Microbead bans, better food-contact materials, reusable packaging	Reduces avoidable release at source	Alternatives also need life-cycle assessment
City	Wastewater upgrades, stormwater interception, tire-wear control	Reduces particle load entering water and air	High cost and limited monitoring standardization
National	Production restrictions, deposit systems, EPR, chemical regulation	Changes industrial incentives	Requires enforcement, transition, and consumer participation
International	Global plastics treaty, transboundary waste rules, harmonized methods	Addresses cross-border pollution and supply chains	Negotiations are complex and politically divided

8. Personal and Technical Prevention: Action Is Possible, but Not Only Personal

Before scientific uncertainty is fully resolved, low-cost and low-harm exposure reduction is reasonable. Individuals can prioritize compliant tap or filtered water over long-term bottled water use; avoid heating high-fat, hot, or acidic foods in plastic containers; reduce repeated heating of plastic; choose products without plastic microbeads; reduce high-frequency washing and drying of synthetic textiles; improve indoor wet cleaning and ventilation; and use glass, stainless steel, or ceramic food-contact materials when feasible.

Technical prevention is more important. Future work should advance low-shedding textiles, washing-machine microfiber filters, tire-wear reduction, standardized monitoring in drinking water and wastewater, food-contact migration testing, reusable packaging systems, traceable recycling, and real degradation assessment for alternative materials. “Biodegradable,” “bio-based,” or “eco-plastic” labels do not automatically mean rapid and harmless degradation in nature. Alternatives require the same rigorous life-cycle and ecotoxicological evaluation.

9. Implications for AIBIOOS Research and Health-Technology Translation

Microplastics should become a long-term observation topic for an AI + life science platform. First, it requires cross-disciplinary knowledge graphs connecting materials science, environmental monitoring, toxicology, clinical cohorts, regulatory policy, and consumer behavior. Second, it requires standardized data: particle size, morphology, polymer type, additives, analytical method, blank contamination control, and sample-processing workflow must become comparable. Third, it has product-translation relevance, including low-exposure lifestyle guidance, food-contact material screening, indoor air and water monitoring, risk education, and enterprise material-substitution assessment.

Most importantly, this topic requires scientific restraint. For the public, microplastics should not be framed as an immediate and simple cause of a specific disease. For industry, they should not be dismissed merely because causality is not fully proven. The responsible position is that existing evidence already supports precautionary reduction, continuous monitoring, and material substitution, while human causal evidence still needs improvement. Waiting for complete certainty before acting may miss the best window for risk governance.

10. Conclusion

The discovery pathway of microplastics entering living systems is now clear: from early reports of plastic particles on the ocean surface in the 1970s, to the establishment of the microplastics concept in 2004, to continuous evidence from ecological experiments, food-web studies, and human biological samples. Microplastics have become a new exposure factor that life science and public health cannot ignore. The strongest evidence concerns environmental ubiquity, biological ingestion, selected experimental toxicity, and detection in multiple human tissues. The evidence that still needs strengthening includes standardized measurement, realistic exposure dose, long-term human cohorts, disease causality, and risk thresholds.

The core appeal of this article is to face microplastic risk scientifically, cautiously, and proactively. Individuals can reduce some exposure through habits. Companies can reduce source release through material design and supply-chain responsibility. Governments can change industrial structures through regulation, monitoring, and economic incentives. International society must coordinate governance across the full plastic life cycle. Microplastics are not merely a matter of personal lifestyle; they are a long-term governance question created when modern material civilization enters biological systems.

Disclaimer: This article is an evidence review and public-health commentary for the AIBIOOS Academic Publications channel. It is intended for academic exchange, health-technology research, policy observation, and product-development reference only. It does not constitute medical diagnosis, treatment advice, or regulatory compliance advice. Personal health risk assessment, occupational exposure, pregnancy exposure, or disease management should be discussed with qualified medical, public-health, or environmental-safety professionals.

References

The references below are based primarily on searchable journal papers, PubMed records, international organization reports, and government regulatory documents. The article separates environmental detection, biological ingestion, human tissue detection, disease association, and national policy responses rather than overstating early or observational evidence as completed human causality.

1. Carpenter EJ, Smith KL Jr. Plastics on the Sargasso Sea surface. Science. 1972;175(4027):1240-1241. doi:10.1126/science.175.4027.1240.
2. Carpenter EJ, Anderson SJ, Harvey GR, Miklas HP, Bradford BP. Polystyrene spherules in coastal waters. Science. 1972;178(4062):749-750. doi:10.1126/science.178.4062.749.
3. Thompson RC, Olsen Y, Mitchell RP, Davis A, Rowland SJ, John AWG, et al. Lost at sea: where is all the plastic? Science. 2004;304(5672):838. doi:10.1126/science.1094559.
4. Arthur C, Baker J, Bamford H, editors. Proceedings of the International Research Workshop on the Occurrence, Effects and Fate of Microplastic Marine Debris. NOAA Technical Memorandum NOS-OR&R-30. 2009.
5. Browne MA, Dissanayake A, Galloway TS, Lowe DM, Thompson RC. Ingested microscopic plastic translocates to the circulatory system of the mussel Mytilus edulis. Environ Sci Technol. 2008;42(13):5026-5031. doi:10.1021/es800249a.
6. Cole M, Lindeque P, Halsband C, Galloway TS. Microplastics as contaminants in the marine environment: a review. Mar Pollut Bull. 2011;62(12):2588-2597. doi:10.1016/j.marpolbul.2011.09.025.
7. Wright SL, Thompson RC, Galloway TS. The physical impacts of microplastics on marine organisms: a review. Environ Pollut. 2013;178:483-492. doi:10.1016/j.envpol.2013.02.031.
8. Rochman CM, Hoh E, Kurobe T, Teh SJ. Ingested plastic transfers hazardous chemicals to fish and induces hepatic stress. Sci Rep. 2013;3:3263. doi:10.1038/srep03263.
9. Van Cauwenberghe L, Janssen CR. Microplastics in bivalves cultured for human consumption. Environ Pollut. 2014;193:65-70. doi:10.1016/j.envpol.2014.06.010.
10. Sussarellu R, Suquet M, Thomas Y, Lambert C, Fabioux C, Pernet MEJ, et al. Oyster reproduction is affected by exposure to polystyrene microplastics. Proc Natl Acad Sci U S A. 2016;113(9):2430-2435. doi:10.1073/pnas.1519019113.
11. Geyer R, Jambeck JR, Law KL. Production, use, and fate of all plastics ever made. Sci Adv. 2017;3(7):e1700782. doi:10.1126/sciadv.1700782.
12. Mason SA, Welch VG, Neratko J. Synthetic polymer contamination in bottled water. Front Chem. 2018;6:407. doi:10.3389/fchem.2018.00407.
13. Cox KD, Covernton GA, Davies HL, Dower JF, Juanes F, Dudas SE. Human consumption of microplastics. Environ Sci Technol. 2019;53(12):7068-7074. doi:10.1021/acs.est.9b01517.
14. Schwabl P, Köppel S, Königshofer P, Bucsics T, Trauner M, Reiberger T, et al. Detection of various microplastics in human stool: a prospective case series. Ann Intern Med. 2019;171(7):453-457. doi:10.7326/M19-0618.
15. World Health Organization. Microplastics in drinking-water. Geneva: WHO; 2019. Available from: https://www.who.int/publications/i/item/9789241516198
16. Ragusa A, Svelato A, Santacroce C, Catalano P, Notarstefano V, Carnevali O, et al. Plasticenta: first evidence of microplastics in human placenta. Environ Int. 2021;146:106274. doi:10.1016/j.envint.2020.106274.
17. Leslie HA, van Velzen MJM, Brandsma SH, Vethaak AD, Garcia-Vallejo JJ, Lamoree MH. Discovery and quantification of plastic particle pollution in human blood. Environ Int. 2022;163:107199. doi:10.1016/j.envint.2022.107199.
18. Jenner LC, Rotchell JM, Bennett RT, Cowen M, Tentzeris V, Sadofsky LR. Detection of microplastics in human lung tissue using μFTIR spectroscopy. Sci Total Environ. 2022;831:154907. doi:10.1016/j.scitotenv.2022.154907.
19. Ragusa A, Notarstefano V, Svelato A, et al. Raman microspectroscopy detection and characterisation of microplastics in human breastmilk. Polymers. 2022;14(13):2700. doi:10.3390/polym14132700.
20. Vethaak AD, Legler J. Microplastics and human health. Science. 2021;371(6530):672-674. doi:10.1126/science.abe5041.
21. Yee MS, Hii LW, Looi CK, Lim WM, Wong SF, Kok YY, et al. Impact of microplastics and nanoplastics on human health. Nanomaterials. 2021;11(2):496. doi:10.3390/nano11020496.
22. Prata JC, da Costa JP, Lopes I, Duarte AC, Rocha-Santos T. Environmental exposure to microplastics: an overview on possible human health effects. Sci Total Environ. 2020;702:134455. doi:10.1016/j.scitotenv.2019.134455.
23. World Health Organization. Dietary and inhalation exposure to nano- and microplastic particles and potential implications for human health. Geneva: WHO; 2022.
24. Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, et al. Microplastics and nanoplastics in atheromas and cardiovascular events. N Engl J Med. 2024;390(10):900-910. doi:10.1056/NEJMoa2309822.
25. United Nations Environment Assembly. Resolution 5/14: End plastic pollution: towards an international legally binding instrument. Nairobi: UNEP; 2022.
26. United Nations Environment Programme. Intergovernmental Negotiating Committee on Plastic Pollution. INC session materials and 2026 updates. Available from: https://www.unep.org/inc-plastic-pollution
27. European Commission. Commission Regulation (EU) 2023/2055: restriction of microplastics intentionally added to products. Brussels: European Commission; 2023.
28. U.S. Food and Drug Administration. The Microbead-Free Waters Act of 2015: FAQs. Silver Spring: FDA; updated 2024.
29. Government of Canada. Microbeads in Toiletries Regulations (SOR/2017-111). Ottawa: Government of Canada; 2017.
30. Government of the United Kingdom. World-leading microbeads ban comes into force. London: GOV.UK; 2018.
31. National Development and Reform Commission of China, Ministry of Ecology and Environment. Opinions on further strengthening plastic pollution control. Beijing; 2020.
32. California State Water Resources Control Board. Microplastics in drinking water program. Sacramento: State Water Resources Control Board; 2020-2022.
33. OECD. Global Plastics Outlook: Economic Drivers, Environmental Impacts and Policy Options. Paris: OECD Publishing; 2022.
34. United Nations Environment Programme. From Pollution to Solution: A global assessment of marine litter and plastic pollution. Nairobi: UNEP; 2021.
35. Hartmann NB, Hüffer T, Thompson RC, Hassellöv M, Verschoor A, Daugaard AE, et al. Are we speaking the same language? Recommendations for a definition and categorization framework for plastic debris. Environ Sci Technol. 2019;53(3):1039-1047. doi:10.1021/acs.est.8b05297.